Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Breast 1

Conditions

Lymphoma 8Small Cell Lung Carcinoma 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hematologic Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Neutropenia 1Bone Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

spartalizumab 1pegylated granulocyte colony-stimulating factor 1anlotinib 1Trabectedin 1Surgical Navigation Systems 1Surgery, Computer-Assisted 1Polymethyl Methacrylate 1Nivolumab 1Microbiota 1Methotrexate 1Metabolome 1Ipilimumab 1Doxorubicin 1Cisplatin 1Bone Plates 1Bone Cements 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Bone Neoplasms × pegylated granulocyte colony-stimulating factor × Clear all
NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Peking University

Phase 4 Unknown
217 enrolled
BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡